Surrozen to Present at Upcoming Healthcare Investor Conference

Company Overview - Surrozen, Inc. is a biotechnology company focused on developing targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration, particularly in severe eye diseases [1][3] - The company utilizes proprietary technologies to harness the body's biological repair mechanisms to treat severe diseases [3] Upcoming Events - Surrozen management will present at the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference on August 13, 2025, starting at 7:00 AM Eastern Time [2] - The presentation will be accessible via an audio webcast on the Surrozen website, with a replay available afterward [2]